Presence of arachidonoyl-carnitine is associated with adverse cardiometabolic responses in hypertensive patients treated with atenolol

Liming Weng, Yan Gong, Jeffrey Culver, Stephen J. Gardell, Christopher Petucci, Alison M. Morse, Reginald F. Frye, Stephen T. Turner, Arlene Chapman, Eric Boerwinkle, John Gums, Amber L. Beitelshees, Peggy R. Borum, Julie A. Johnson, Timothy J. Garrett, Lauren M. McIntyre, Rhonda M. Cooper-DeHoff

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Presence of arachidonoyl-carnitine is associated with adverse cardiometabolic responses in hypertensive patients treated with atenolol'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds